Warner Carr

643 total citations
21 papers, 145 citations indexed

About

Warner Carr is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Warner Carr has authored 21 papers receiving a total of 145 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology and Allergy. Recurrent topics in Warner Carr's work include Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (11 papers) and Eosinophilic Esophagitis (4 papers). Warner Carr is often cited by papers focused on Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (11 papers) and Eosinophilic Esophagitis (4 papers). Warner Carr collaborates with scholars based in United States, United Kingdom and Poland. Warner Carr's co-authors include Christopher S. Ambrose, Weily Soong, Reynold A. Panettieri, Jennifer Trevor, Dennis K. Ledford, Njira Lugogo, Frank Trudo, Wendy C. Moore, Bradley E. Chipps and Jay M. Portnoy and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Annals of Allergy Asthma & Immunology and Pharmacoepidemiology and Drug Safety.

In The Last Decade

Warner Carr

15 papers receiving 141 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Warner Carr United States	8	91	69	37	36	24	21	145
Giuseppe Valenti Italy	11	246 2.7×	188 2.7×	48 1.3×	100 2.8×	31 1.3×	17	288
C.A. Celis-Preciado Colombia	5	173 1.9×	99 1.4×	10 0.3×	55 1.5×	47 2.0×	18	233
Eliana Toledo Brazil	6	30 0.3×	26 0.4×	29 0.8×	11 0.3×	21 0.9×	13	131
Maximiliano Gómez Argentina	6	56 0.6×	12 0.2×	79 2.1×	60 1.7×	15 0.6×	11	155
Bassam Mahboub United Arab Emirates	7	109 1.2×	77 1.1×	18 0.5×	48 1.3×	23 1.0×	13	179
Almudena Testera‐Montes Spain	11	185 2.0×	40 0.6×	17 0.5×	217 6.0×	31 1.3×	19	270
Clairelyne Dupin France	8	72 0.8×	103 1.5×	30 0.8×	13 0.4×	42 1.8×	32	181
Aaron Juche Germany	3	33 0.4×	132 1.9×	95 2.6×	9 0.3×	11 0.5×	8	148
Lawrence McDermott United States	4	81 0.9×	253 3.7×	30 0.8×	5 0.1×	16 0.7×	7	281
Hiroshi Kitazawa Japan	8	36 0.4×	47 0.7×	6 0.2×	24 0.7×	50 2.1×	23	152

Countries citing papers authored by Warner Carr

Since Specialization

Citations

This map shows the geographic impact of Warner Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warner Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warner Carr more than expected).

Fields of papers citing papers by Warner Carr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warner Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warner Carr. The network helps show where Warner Carr may publish in the future.

Co-authorship network of co-authors of Warner Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Warner Carr. A scholar is included among the top collaborators of Warner Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warner Carr. Warner Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soong, Weily, Bradley E. Chipps, Warner Carr, et al.. (2024). Quality of Life Improvements with Biologic Initiation Among Subspecialist-Treated US Patients with Severe Asthma. Journal of Asthma and Allergy. Volume 17. 441–448. 1 indexed citations

Ledford, Dennis K., Warner Carr, Wendy C. Moore, et al.. (2024). Reduced Effectiveness of Anti-IgE Treatment Among Adults with Severe Asthma with Older Age of Asthma Onset: Results from the CHRONICLE Study. Journal of Asthma and Allergy. Volume 17. 977–982. 1 indexed citations

Giménez‐Arnau, Ana M., Koremasa Hayama, Adam Reich, et al.. (2023). Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks. Journal of Allergy and Clinical Immunology. 153(2). 479–486.e4. 40 indexed citations

Chipps, Bradley E., Weily Soong, Reynold A. Panettieri, et al.. (2023). Number of patient-reported asthma triggers predicts uncontrolled disease among specialist-treated patients with severe asthma. Annals of Allergy Asthma & Immunology. 130(6). 784–790.e5. 8 indexed citations

Ledford, Dennis K., Weily Soong, Warner Carr, et al.. (2023). Real-world severe asthma biologic administration and adherence differs by biologic. Annals of Allergy Asthma & Immunology. 131(5). 598–605.e3. 18 indexed citations

Panettieri, Reynold A., Dennis K. Ledford, Bradley E. Chipps, et al.. (2022). Biologic use and outcomes among adults with severe asthma treated by US subspecialists. Annals of Allergy Asthma & Immunology. 129(4). 467–474.e3. 14 indexed citations

Chipps, Bradley E., Njira Lugogo, Warner Carr, et al.. (2022). Clinical Remission with Biologic Use Among US Subspecialist-treated Patients with Severe Asthma: Results from the CHRONICLE Study. Journal of Allergy and Clinical Immunology. 149(2). AB147–AB147. 1 indexed citations

Beachler, Daniel C., Devon H. Taylor, Mary S. Anthony, et al.. (2021). Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data. Pharmacoepidemiology and Drug Safety. 30(7). 918–926. 5 indexed citations

Trevor, Jennifer, Njira Lugogo, Warner Carr, et al.. (2021). Severe asthma exacerbations in the United States:. Annals of Allergy Asthma & Immunology. 127(5). 579–587.e1. 25 indexed citations

10.

Moore, Wendy C., Reynold A. Panettieri, Jennifer Trevor, et al.. (2020). Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma. Annals of Allergy Asthma & Immunology. 125(3). 294–303.e1. 11 indexed citations

11.

Hickey, Lisa, Warner Carr, & Margaret Garin. (2019). Clinically meaningful improvements in asthma control questionnaire (ACQ) scores occur early, while asthma-related quality of life (AQLQ) scores continue to improve over 52 weeks, among patients with eosinophilic asthma receiving IV reslizumab. Journal of Allergy and Clinical Immunology. 143(2). AB96–AB96. 1 indexed citations

12.

Soong, Weily, Warner Carr, Bradley E. Chipps, et al.. (2019). Demographic Characteristics, Comorbidities, and Exacerbation Frequency Among Patients Enrolled in the Chronicle Study: A Real-World, Prospective, Observational Study of US, Subspecialist-Treated Adults with Severe Asthma. Journal of Allergy and Clinical Immunology. 143(2). AB429–AB429. 1 indexed citations

13.

Carr, Warner, Brian P. Vickery, Rezi Zawadzki, et al.. (2019). Estimating the Probability of Tolerating Each Challenge Dose of Peanut Protein at Exit Double-Blind, Placebo-Controlled Food Challenge: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE) of AR101. Journal of Allergy and Clinical Immunology. 143(2). AB262–AB262.

14.

Carr, Warner, David J. Jackson, Jonathan Corren, et al.. (2019). Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma by Immunoglobin E Levels at Baseline. PA536–PA536.

15.

Moore, Wendy C., Warner Carr, Bradley E. Chipps, et al.. (2019). Real-World Biologic Medication Use in a Diverse Population of US, Specialist-Treated Adults with Severe Asthma -Results of CHRONICLE Study. A2679–A2679.

16.

Ambrose, Christopher S., Warner Carr, Bradley E. Chipps, et al.. (2019). Characteristics of US, Subspecialist-Treated Adults with Severe Asthma Receiving and Not Receiving Therapy with Biologic Medications in the CHRONICLE Study. A2678–A2678.

17.

Hampel, Frank C., et al.. (2017). Evaluation of beclomethasone dipropionate (80 and 160 micrograms/day) delivered via a breath-actuated inhaler for persistent asthma. Allergy and Asthma Proceedings. 38(6). 419–430.

18.

Carr, Warner, et al.. (2017). P223 Reslizumab improves spirometric lung age in patients with severe eosinophilic asthma. Annals of Allergy Asthma & Immunology. 119(5). S57–S57. 1 indexed citations

19.

Acaster, Sarah, Warner Carr, Phil Lieberman, Claus Bachert, & David Price. (2012). Treatment preferences in patients with moderate-severe seasonal allergic rhinitis: findings of a discrete choice experiment. Annals of Allergy Asthma & Immunology. 109. 7 indexed citations

20.

Nelson, Harold S., Warner Carr, Robert A. Nathan, & Jay M. Portnoy. (2009). Update on the safety of long-acting β-agonists in combination with inhaled corticosteroids for the treatment of asthma. Annals of Allergy Asthma & Immunology. 102(1). 11–15. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact